Asciminib With or Without Sildenafil for Brain Tumors

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2027

Conditions

Brain Tumor

Interventions

DRUG

Asciminib

Commercially available stock

DRUG

Sildenafil

Commercially available stock

PROCEDURE

Surgical resection or biopsy

Standard of care

Trial Locations (1)

Washington University School of Medicine/St. Louis Children's Hospital, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT07039760 - Asciminib With or Without Sildenafil for Brain Tumors | Biotech Hunter | Biotech Hunter